Author: Xiong, Xiaomo; Yuan, Jing; Li, Minghui; Jiang, Bin; Lu, Z. Kevin
Title: Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management Cord-id: w7mh9xj6 Document date: 2021_7_19
ID: w7mh9xj6
Snippet: Background: Two coronavirus disease 2019 (COVID-19) vaccines have received emergency use authorizations in the U.S. However, the safety of these vaccines in the real-world remains unknown. Methods: We reviewed adverse events (AEs) following COVID-19 vaccination among adults in the Vaccine Adverse Event Reporting System (VAERS) from December 14, 2020, through January 22, 2021. We compared the top 10 AEs, serious AEs, along with office and emergency room (ER) visits by age (18–64 years, ≥65 ye
Document: Background: Two coronavirus disease 2019 (COVID-19) vaccines have received emergency use authorizations in the U.S. However, the safety of these vaccines in the real-world remains unknown. Methods: We reviewed adverse events (AEs) following COVID-19 vaccination among adults in the Vaccine Adverse Event Reporting System (VAERS) from December 14, 2020, through January 22, 2021. We compared the top 10 AEs, serious AEs, along with office and emergency room (ER) visits by age (18–64 years, ≥65 years) and gender (female, male). Results: There were age and gender disparities among adults with AEs following COVID-19 vaccination. Compared to younger adults aged between 18 and 64 years, older adults were more likely to report serious AEs, death, permanent disability, and hospitalization. Males were more likely to report serious AEs, death, and hospitalization compared to females. Conclusions: COVID-19 vaccines are generally safe but possible age and gender disparities in reported AEs may exist.
Search related documents:
Co phrase search for related documents- adaptive innate and administration dose: 1
- adaptive innate and administration type: 1, 2, 3
- adaptive innate and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8
- adaptive innate and low ability: 1
- adaptive innate and low frequency: 1, 2, 3, 4
- adaptive innate immune response and logistic regression: 1, 2, 3
- additional study and administration dose: 1, 2
- additional study and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- additional study and long term effect: 1
- additional study and low frequency: 1
- adjusted odd ratio and logistic regression: 1, 2, 3, 4, 5
- adjusted odd ratio and logistic regression model: 1, 2
- administration dose and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8
- administration dose and logistic regression model: 1
- administration dose and long term effect: 1
- logistic regression and long term effect: 1, 2
- logistic regression and low ability: 1, 2, 3, 4, 5, 6, 7, 8
- logistic regression and low frequency: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- logistic regression model and low frequency: 1
Co phrase search for related documents, hyperlinks ordered by date